For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The North America region was the highest contributor to the global osseointegration implants market, generating $XX million in 2018, and is projected to reach $XX million by 2027. The North America osseointegration implants market is estimated to advance at a CAGR of 6.28% during the forecasting years of 2019-2027.
The increasing geriatric population with orthopedic diseases, preference for minimally invasive surgeries and the advancement in technology are primarily propelling the market advancement for osseointegration implants in North America. The demand for minimally invasive implants procedures has increased the growth of the market tremendously. North America held the largest market share globally and is projected to grow at a steady pace during the forecast period. The countries like the United States and Canada are considered for the market analysis.
Zimmer Biomet Holdings Inc., Integrum AB, Medtronic, Henry Schein, Inc., Bicon LLC, Institut Straumann, Danaher Corp., Dentsply Sirona Inc., Smith and Nephew PLC, 3M Company, Stryker Corporation, and Osstem Implant Co. Ltd. are the major market players in the region.